Skip to main content

Desloratadine / pseudoephedrine Side Effects

Medically reviewed by Drugs.com. Last updated on Jan 22, 2024.

Applies to desloratadine / pseudoephedrine: oral tablet extended release 12 hr, oral tablet extended release 24 hr.

Serious side effects

Along with its needed effects, desloratadine/pseudoephedrine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking desloratadine / pseudoephedrine:

Observed during clinical practice

Symptoms of overdose

Get emergency help immediately if any of the following symptoms of overdose occur while taking desloratadine / pseudoephedrine:

Other side effects

Some side effects of desloratadine / pseudoephedrine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to desloratadine / pseudoephedrine: oral tablet extended release.

Psychiatric

Very common (10% or more): Insomnia (10%)[Ref]

Cardiovascular

Frequency not reported: Arrhythmias, cardiovascular collapse with accompanying hypotension

Postmarketing reports: Tachycardia, palpitations[Ref]

Hypersensitivity

Frequency not reported: Hypersensitivity reactions (including rash, pruritus, urticaria, edema, dyspnea, and anaphylaxis)[Ref]

Nervous system

Common (1% to 10%): Headache, somnolence, dizziness

Frequency not reported: Insomnia, tremor, nervous system stimulation with convulsions[Ref]

Gastrointestinal

Common (1% to 10%): Mouth dry, nausea[Ref]

Dermatologic

Frequency not reported: Severe skin reactions

Postmarketing reports: Rash, pruritus[Ref]

Metabolic

Common (1% to 10%): Anorexia[Ref]

Ocular

Frequency not reported: Narrow-angle glaucoma[Ref]

Genitourinary

Frequency not reported: Urinary retention in patients with prostatic hypertrophy[Ref]

Respiratory

Common (1% to 10%): Pharyngitis

Postmarketing reports: Dyspnea[Ref]

Other

Frequency not reported: Weakness[Ref]

References

1. Product Information. Clarinex-D 12 Hour (desloratadine-pseudoephedrine). Schering-Plough Healthcare Products. 2019.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.